The European Parliament approved the text on April 17, 2014 of a long-awaited Directive designed to facilitate private actions for damages by victims of infringements of antitrust rules in the EU (the “Directive”). The...more
Lessons from the latest Commission decision on agreements affecting generic entry:
- The European Commission’s crack down on so-called “reverse payment” agreements continues.
- In the EU these agreements may...more
12/23/2013
/ Competition ,
Corporate Counsel ,
EU ,
European Commission ,
Federal Trade Commission (FTC) ,
Fines ,
FTC v Actavis ,
Generic Drugs ,
Johnson & Johnson ,
Novartis ,
Pharmaceutical Industry ,
Reverse Payment Settlement Agreements
Highlights:
- Higher market share thresholds are expected to increase the number of cases benefiting from the simplified procedure by approximately 10%.
- Joint ventures with no activities in the EEA qualify for...more